Harmony Biosciences Holdings (HRMY) Change in Acquisitions & Divestments (2022 - 2026)

Harmony Biosciences Holdings has disclosed Change in Acquisitions & Divestments across 5 years of filings, most recently posting $27.3 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $27.3 million, up 26.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.8 million (down 14.26% YoY), and the FY2025 annual result was $81.1 million, down 17.73% from the prior year.
• Change in Acquisitions & Divestments came in at $27.3 million for Q1 2026 at Harmony Biosciences Holdings, up from $20.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $46.0 million in Q1 2023 to a low of $8.2 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $22.1 million (2023), against an average of $23.8 million.
• Across the five-year window, Change in Acquisitions & Divestments soared 175.98% in 2023 and slumped 58.85% in 2024, its largest moves.
• Harmony Biosciences Holdings' Change in Acquisitions & Divestments stood at $8.2 million in 2022, then soared by 175.98% to $22.6 million in 2023, then soared by 32.66% to $30.0 million in 2024, then slumped by 31.49% to $20.6 million in 2025, then surged by 33.01% to $27.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $27.3 million (Q1 2026), $20.6 million (Q4 2025), and $19.6 million (Q3 2025), per Business Quant data.